Sleep disruption is a common feature of neurodevelopmental disorders. As such, gaining a detailed mechanistic understanding of sleep circuit development will help elucidate causative factors in neurodevelopmental sleep disorders. Previous work has illuminated aspects of the development of sleep controlling neurons ALA (van Buskirk and Sternberg '10) and RIS (Turek et al '13), but much is yet to be discovered regarding the larger sleep circuit and how sleep signals are interpreted by the body. C. elegans experience stress or sickness induced sleep (SIS) in response to infection, radiation treatment, heat shock, or osmotic stress. During SIS, the ALA neuron is activated by Epidermal Growth Factor (EGF) to release the sleep-inducing neuropeptides FLP-13, FLP-24, and NLP-8. Differential effects of these peptides on feeding and movement quiescence suggest that parallel pathways regulate different aspects of quiescence during sleep (Nath et al, '16). Myocyte Enhancer Factor 2 (MEF-2) is a transcription factor that regulates the expression of genes involved in development of both muscles and neurons. In C. elegans,
mef-2 regulates muscle to neuron signaling at the neuromuscular junction (Simon et al, '08). We find that animals lacking
mef-2 function are defective in movement but not feeding quiescence during SIS. Mef-2 mutants are resistant to EGF but not FLP-13 overexpression induced movement quiescence, suggesting that
mef-2 functions in the development of the ALA neuron. Surprisingly, we find that muscle (
myo-3 promoter) but not neural (
rab-3 promoter)
mef-2 expression rescued the SIS defects in these animals. Our working hypothesis is that
mef-2 regulates the development of neuronal sleep circuitry by acting in muscle cells.